Posts Tagged ‘severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)’
Interleukin-33 involved in SARS-CoV-2 immunity
New study links the production of cytokine interleukin 33 to SARS-CoV-2 immunity, which could have implications for future COVID-19 therapies. …
Read Full ArticleCOVID-19 causes unexpected cellular response in the lungs
A biochemical pathway, known as the immune complement system, is unexpectedly triggered in lung cells by SARS-CoV-2, which might explain why COVID-19 is so difficult to treat. …
Read Full ArticleOne in ten have long-term effects 8 months following mild COVID-19
Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom with an impact on quality of life. …
Read Full ArticleCOVID-19 survivors might need just one dose of two-part vaccine
A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence …
Read Full ArticleB.1.1.7 variant of COVID-19 spreading rapidly in United States
Genetic analysis of coronavirus samples suggests the UK-originating variant of COVID-19, which is 40-50 percent more transmissible, entered the US in late November 2020. …
Read Full ArticleAnti-inflammatory drug protects against lethal inflammation from COVID-19 in animal models
A widely available and inexpensive anti-inflammatory drug, topotecan, reduced morbidity and mortality in mice infected with SARS-CoV-2. …
Read Full ArticleT cells recognize recent SARS-CoV-2 variants
New research suggests T-cells from recovered COVID-19 patients recognize the major SARS-CoV-2 variants. …
Read Full ArticleEvidence for reduced antibody protection against SARS-CoV-2 variants
Cell culture studies show that SARS-CoV-2 variants are less susceptible to inhibition by antibodies from recovered or vaccinated individuals. …
Read Full ArticleSARS-CoV-2 infection of mouth cells: Potential role of saliva in viral transmission
New research shows the mouth is an important site for SARS-CoV-2 infection and saliva is a potential route of viral transmission. …
Read Full ArticleCOVID-19 vaccines may not produce sufficient antibody response in transplant recipients
Immunocompromised transplant recipients who received their first dose of COVID-19 mRNA vaccine show poor immunogenic response as only 17 percent produced detectable SARS-CoV-2 antibodies. …
Read Full Article